¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Wiskott-Aldrich Syndrome Protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • gay bowel syndrome
    µ¿¼º¾ÖÀÚâÀÚÁõÈıº
  • general adaptation syndrome
    Àü½Å¼øÀÀÁõÈıº
  • Goodpasture¡¯s syndrome
    ±ÂÆÄ½ºÃ³ÁõÈıº
  • gray syndrome
    ȸ»öÁõÈıº
  • Guillain-Barre syndrome
    ±æ·©-¹Ù·¹ÁõÈıº
  • Ganser syndrome
    °£ÀúÁõÈıº
  • hypereosinophilic syndrome
    °ú´ÙÈ£»ê±¸ÁõÈıº
  • hyper-IgM syndrome
    °í¸é¿ª±Û·ÎºÒ¸°MÁõÈıº
  • hyperimmunoglobulin E syndrome
    °í¸é¿ª±Û·ÎºÒ¸°EÁõÈıº
  • hyperstimulation syndrome
    °ú´ÙÀÚ±ØÁõÈıº
  • hyperventilation syndrome
    °ú´Ùȯ±âÁõÈıº
  • hyperviscosity syndrome
    °ú´ÙÁ¡¼ºÁõÈıº
  • hypoventilation syndrome
    Àúȯ±âÁõÈıº
  • hemolytic uremic syndrome
    ¿ëÇ÷¿äµ¶ÁõÈıº
  • hemopleuropneumonic syndrome
    Ç÷¾×°¡½¿¸·Æó·ÅÁõÈıº, Ç÷¾×È丷Æó·ÅÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • immersion foot syndrome
    ħ¼ö¹ßÁõÈıº, ¹ß´ã±ÝÁõÈıº
  • immune amnesia syndrome
    ¸é¿ª±â¾ï»ó½ÇÁõÈıº
  • immunoproliferative syndrome
    ¸é¿ª¼¼Æ÷Áõ½ÄÁõÈıº
  • impingement syndrome
    ºÎµúÈûÁõÈıº
  • infantile stiff skin syndrome
    ¿µ¾ÆÇǺΰæÁ÷ÁõÈıº
  • interosseous nerve syndrome
    »À»çÀ̽ŰæÁõÈıº, °ñ°£½Å°æÁõÈıº
  • intersection syndrome
    ±³Â÷ÁõÈıº
  • intracerebral steal syndrome
    ³ú³»Ç÷·ùÀúÇÏÁõÈıº
  • irritable bowel syndrome
    °ú¹Î´ëÀåÁõÈıº
  • irritation syndrome
    ÀÚ±ØÁõÈıº
  • Jadassohn-Lewandowsky syndrome
    (¢¡pachyonychia congenita) ¼±Ãµ¼Õ¹ßÅéºñ´ëÁõ
  • jet lag syndrome
    ºñÇà½ÃÂ÷ÁõÈıº
  • lazy bladder syndrome
    °ÔÀ¸¸§¹æ±¤ÁõÈıº
  • locked-in syndrome
    °¨±ÝÁõÈıº
  • lymphadenopathy syndrome
    ¸²ÇÁÀýº´ÁõÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Ganser syndrome
    °µ¼­ÁõÈıº.
  • Gardner s syndrome
    °¡¾Æµå³ÊÁõÈıº.
  • Gianotti-Crosti syndrome => infantile papular acrodermatitis
    Àð³ëƼ Å©·Î½ºÆ¼ ÁõÈıº
  • Gilberts syndrome
    Áúº£¸£ÁõÈıº
  • Glucose-galactose malabsorption syndrome
    ±Û·çÄÚ¿À½º-°¥¶ôÅ佺Èí¼öÀå¾ÖÁõÈıº(ýåâ¥î¡äôñøý¦ÏØ)
  • Goldenhars syndrome->oculo-auriculo-vertebral dysplasia
    °ñµçÇÏÁõÈıº
  • Goltzs syndrome => focal dermal hypoplasia
    ±¹¼Ò ÁøÇÇ Çü¼ººÎÀüÁõ
  • Golzs syndrome
    °ñÁî ÁõÈıº
  • Goodpasture s syndrome
    ±¸µåÆÐ½ºÃò¾î ÁõÈıº.
  • Gradenigos syndrome
    Ãßü(÷ºÎ)¿° ÁõÈıº, ±×¶óµ¥´Ï
  • Graham-Little syndrome
    ±×·¹À̾ö ¸®Æ² ÁõÈıº
  • Grey platelet syndrome
    ±×·¹ÀÌÇ÷¼ÒÆÇÁõÈıº
  • Guillain Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº.
  • Guillain-Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº
  • HELLP syndrome
    HELLP ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • structural protein
    ±¸Á¶ ´Ü¹é
  • tamm-horsfall protein
    Ž-È£½ºÆú´Ü¹é
  • thyroxin binding protein
    Ƽ·Ï½Å°áÇմܹéÁú(¡­Ì¿ùêÓ±ÛÜòõ).
  • tidal plasma protein
    ¼øÈ¯Ç÷Àå´Ü¹é·®(âàü»úìíìÓ±ÛÜåÖ).
  • tissue protein
    Á¶Á÷´Ü¹éÁú(¡­Ó±ÛÜòõ).
  • total protein
    ÃѴܹ鷮(õÅÓ±ÛÜåÖ).
  • total serum protein
    ÃÑÇ÷û´Ü¹é(·®).
  • vehicle protein
    ´Ü¹éÁú(Ó±ÛÜòõ)¿î¹ÝÀÚ.
  • viral protein
    ¹ÙÀÌ·¯½º´Ü¹é(¡­Ó±ÛÜ).
  • viral protein (VP)
    ¹ÙÀÌ·¯½º ´Ü¹é
  • abdominal muscle deficiency syndrome
    º¹±Ù°á¼ÕÁõÈıº(ÜÙÐÉÌÀáßñøý¦ÏØ).
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent testes syndrome
    °íȯ°á¿©ÁõÈıº
  • abstinence syndrome
    ±Ý´ÜÁõÈıº(Ð×Ó¨ñøý¦ÏØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • protein modification
    ´Ü¹éÁú ¼ö½Ä(Ó±ÛÜòõáóãÞ)
  • protein overloading
    ´Ü¹éÁú°úºÎÇÏ(Ó±ÛÜòõΦݶùÃ)
  • protein processing
    ´Ü¹éÁú °¡°ø(Ó±ÛÜòõÊ¥Íï)
  • protein release factor
    ´Ü¹éÁú ¹æÃâÀÎÀÚ(Ó±ÛÜòõÛ¯õóì×í­)
  • protein score
    ´Ü¹éÁú°¡(Ó±ÛÜòõʤ)
  • protein sequencer
    ´Ü¹éÁú¼­¿­±â(Ó±ÛÜòõßíÖªÐï)
  • protein sequencing
    ´Ü¹éÁú ¼­¿­ °áÁ¤(Ó±ÛÜòõßí֪̽ïÒ)
  • protein-sparing action
    ´Ü¹éÁú Àý¾à ÀÛ¿ë(Ó±ÛÜòõï½å³íÂéÄ)
  • protein structure
    ´Ü¹éÁú ±¸Á¶(Ó±ÛÜòõϰðã)
  • protein synthesis
    ´Ü¹éÁú ÇÕ¼º(Ó±ÛÜòõùêà÷)
  • protein synthesis factor
    ´Ü¹éÁú ÇÕ¼ºÀÎÀÚ(Ó±ÛÜòõùêà÷ì×í­)
  • protein-synthesizing system
    ´Ü¹éÁú ÇÕ¼º(Ó±ÛÜòõùêà÷) ½Ã½ºÅÛ
  • protein turnover
    ´Ü¹éÁú Àüȯ(Ó±ÛÜòõï®üµ)
  • protein value
    ´Ü¹éÁú(Ó±ÛÜòõ)°ª
  • read-through protein
    ÆÇµ¶ ´Ü¹éÁú(÷÷ÔÁÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
HSP Health Systems Plan; heat shock protein; hemostatic screening profile; Henoch-Schonlein purpura; her...
IAP immunosuppressive acidic protein; inosinic acid pyrophosphorylase; Institute of Animal Physiology; i...
IBP insulin-like growth factor binding protein; International Biological Program; intra-aortic balloon p...
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
LSP left sacroposterior [fetal position]; linguistic string project; liver-specific protein; lymphocyte-...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
CSWS Cerebral Salt Wasting Syndrome
CBS Charles Bonnet Syndrome
CHS Che'diak-Higashi syndrome
CCS Chronic Compartment Syndrome
CFS Chronic Fatigue Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dermatorheumatismal syndrome
    ÇǺΠ·ù¸¶Æ¼½º ÁõÈıº
  • Devies syndrome
    µ¥ºò ÁõÈıº
  • Di George's syndrome
    µð, ÁÒ¿ÀÁö ÁõÈıº
    1. Èä¼±ÀÌ Çü¼ºµÇÁö ¸øÇÏ´Â Èä¼± ¹«Çü¼ºÁõÀ» µ¿¹ÝÇϹǷΠÀÎÇØ ¹ß»ýÇÏ´Â ¼¼Æ÷ ¸Å°³¼º ¸é¿ªÀÇ °áÇÌÀÌ ³ªÅ¸³ª´Â Áúº´. 2. Èä¼±ÀÇ ¹«Çü¼º ³»Áö ÀúÇü¼º°ú ¼±Ãµ¼º ½ÉÁúȯ. ºÎ°©»ó¼± ÀÌ»óÁõÀ» ¼ö¹Ý½ÃŰ´Â ¼±Ãµ¼º ¼¼Æ÷¼º ¸é¿ª ºÎÀü ÁõÈıºÀÌ¸ç ¸· ž ¶§¿¡ º¼ ¼ö ÀÖ´Â À̰³ÀÇ ÀúÀ§, ¾î»ó±¸ ¾ç¾ÈÀÇ °Ý¸® µîÀÇ Æ¯À¯ ¾È¸ð¿Í ºÎ°©»ó¼± ±â´É Å»¶ô¿¡ ÀÇÇÑ Àú Ä®½· Ç÷Áõ, ¿ïÇ÷¼º ½ÉºÎÀü µî¿¡ ÀÇÇÏ¿© ÀǽÉÀ» °¡Áö°Ô µÇ°í Èä¼± ¹× T¼¼Æ÷ ±â´ÉÀÇ °Ë»öÀ¸·Îµµ Áø´ÜÀÌ ³»·ÁÁø´Ù. º´ÀÎÀ¸·Î¼­´Â ÀÌ»óÁ¦±â°ü »çÀÌÀÇ °ü·Ã¿¡¼­ Å»ý 12ÁÖ °æÀÇ ¹ß»ý ÀÌ»óÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù.
  • diencephalic-hypophysial syndrome
    °£³ú Çϼöü ÁõÈıº
    ¿äºØÁõ, Áö¹æÁõ, ¼º±â À§Ãà, ½Ã¸óÁ µîÀÇ ÃÑĪ. °£³ú, ƯÈ÷ ½Ã»ó ÇϺο¡´Â ¿©·¯ °¡Áö ÀÚÀ²½Å°æ ÁßÃß°¡ Àִµ¥, °£³ú ÇϼöüÀÇ ¿¬°áÀº ÇØºÎÇлóÀ¸·Î³ª ±â´É»óÀ¸·Îµµ ±ØÈ÷ ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Â °ÍÀÌ ¸í¹éÇØÁ®¼­, Áö±Ý±îÁö ³úÇϼöü°èÀÇ Àå¾Ö·Î ¸»¹Ì¾Ï¾Æ »ý±ä´Ù°í »ý°¢µÇ¾î¿Â À§À庴 µîÀÇ Áõ¼¼´Â °£³ú ÁßÃßÀÇ Àå¾Ö¸¸À¸·Î »ý±ä´Ù´Â °ÍÀÌ ¹àÇôÁ³´Ù.
  • diffuse hemorrhagic syndrome
    ¹Ì¸¸¼º ÃâÇ÷¼º ÁõÈıº
  • Digeorge syndrome
    Digeorge ÁõÈıº
    À¯Àü¼º ¸é¿ª °á¼ÕÀÇ ÇÑ Á¾·ù·Î Èä¼± Çü¼º ºÎÀü°ú ¼¼Æ÷¼º ¸é¿ª ±â´ÉÀÇ °¨¼Ò·Î ³ªÅ¸³­´Ù.
  • discrete multiple endocrine adenomatosis syndrome
    ºÐ¸®¼º ´Ù¹ß ³»ºÐºñ ¼±Á¾ ÁõÈıº
  • dorsal midbrain syndrome
    ÈÄÁß³ú ÁõÈıº
  • double crush syndrome
    ÀÌÁß ºÐ¼â ÁõÈıº
  • Dresslers syndrome
    µå·¹½½·¯ ÁõÈıº
  • Duanes retraction syndrome
    µà¾È ¾È±¸ ÈÄÅð ÁõÈıº
  • dysconnection syndrome
    ºÐ¸® ÁõÈıº
  • dyskinetic syndrome
    ¿îµ¿ Àå¾Ö ÁõÈıº
  • dysplastic nevus syndrome
    ÀÌÇü¼º ¸ð¹Ý ÁõÈıº
  • dysuria-pyuria syndrome
    ¹è´¢ Àå¾Ö-³ó´¢ ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
myeloma protein <haematology, oncology> The immunoglobulins and Bence Jones proteins secreted by myeloma cells.
(18 Nov 1997)
myod protein A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, myod appears to be related to fusion and terminal differentiation of the muscle cell.
(12 Dec 1998)
C protein <cell biology> Striated muscle thick filament associated proteins (140-150 kD) that show up in the C zone of the A band as 43nm transverse stripes. Structurally related to various other myosin binding proteins (twitchin, titin, myosin light chain kinase, skelemin, 86 kD protein, projectin, M protein).
(18 Nov 1997)
myotonin-protein kinase <enzyme> Has been sequenced
Registry number: EC 2.7.-
Synonym: mtpk, myotonin protein kinase
(26 Jun 1999)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
CRK4 protein kinase <enzyme> From mouse, has 85% amino acid identity with xenopus m015 protein kinase; genbank x74145
Registry number: EC 2.7.10.-
Synonym: crk4 pk
(26 Jun 1999)
H1-related protein-tyrosine phosphatase <enzyme> Has tyrosine and threonine/serine phosphatase activities
Registry number: EC 3.1.3.-
Synonym: vaccinia virus h1-related protein tyrosine phosphatase, vhr ptpase, vh-ptp13
(26 Jun 1999)
cro protein <protein> Protein synthesised by bacteriophage lambda in the lytic state. The cro protein blocks the synthesis of the lambda repressor (that is produced in the lysogenic stage and inhibits cro protein synthesis). Production of the cro protein in turn controls a set of genes associated with rapid virus multiplication.
(18 Nov 1997)
haemagglutinin-neuraminidase protein <protein> A protein found in the capsid of the Sendai virus which is exceptionally good at binding to the cytoplasmic membranes of many animal cells. The protein is therefore used to make fusogenic vesicles for the purpose of delivering therapeutic drugs or other chemicals directly into cells.
(09 Oct 1997)
crude protein Incomplete proteins which lack essential amino acids.
(09 Oct 1997)
crystalline protein <protein> The major protein found in the lens of the vertebrate eye, it can be dissolved in water easily.
(09 Oct 1997)
Csk-like protein-tyrosine kinase <enzyme> Phosphorylates c-terminal conserved tyr of src family members; from mouse brain; has 52% identity with mouse csk; mw 52 kD; genbank u05210
Registry number: EC 2.7.1.-
Synonym: ctk (kinase), ctk gene product, csk-type protein-tyrosine kinase, ntk (kinase), bhk (kinase)
(26 Jun 1999)
C-terminal leucine protein methyltransferase <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues
Registry number: EC 2.1.1.-
Synonym: tlp methyltransferase
(26 Jun 1999)
PP5 protein-serine-threonine phosphatase <enzyme> Has 4 tetratricopeptide repeat (tpr) motifs; similar to ppt1 protein; do not confuse with the placental protein pp5; amino acid sequence given in first source
Registry number: EC 3.1.3.-
Synonym: pp5 phosphatase, protein phosphatase 5
(26 Jun 1999)
pp65 protein <protein> A protein made by a cytomegalovirus which prevents the cell that the virus has infected from displaying fragments of viral proteins, called antigens, on the cells surface. In this way the cytomegalovirus is able to evade the bodys immune system, more or less permanently.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á